Radionuclides/Radiopharmaceuticals and Diagnostic Scanning Uses
Radionuclide/Radiopharmaceutical | Organ/Study |
---|---|
Technetium 99m (99mTc)![]() | |
Technetium Tc 99m pertechnetate | Braindelayed imaging Cardiac gated blood pool imaging Thyroid gland Parathyroid gland Parotid and salivary glands Scrotum and contents Meckel's diverticulum |
Technetium Tc 99m stannous pyrophosphate | Cardiac infarction Cardiac gated blood pool imaging |
Technetium Tc 99m diethylenetriamine pentaacetic acid (DTPA) | Brainearly imaging Cerebrospinal fluid flow imaging Renal glomerular filtration rate and blood flow imaging |
Technetium Tc 99m RBC or albumin | Gastrointestinal bleeding |
Technetium Tc 99m sulfur colloid | Gastrointestinal bleeding Gastric emptying Gastroesophageal reflux Esophageal motility Liver and spleen Bone marrow |
Technetium Tc 99m glucoheptonate | Brainearly imaging Renal structural defects |
Technetium Tc 99m hydroxyethylene | Bone and joint diphosphonate (HEDP) |
Technetium Tc 99m methylene diphosphonate (MDP) | Bone and joint |
Technetium Tc 99m albumin (MAA or HAM) | Lung perfusion |
Technetium Tc 99m diisopropyl (IDA) | Gallbladder and biliary systems |
Technetium Tc 99m dimercaptosuccinic acid (DMSA) | Renal excretion |
Indium 111 (111In)![]() | |
Indium In 111 diethylenetriamine pentaacetic acid (DTPA) | CSF flow imaging |
Indium In 111 chloride | Bone marrow Gastric emptying |
Indium In 111 WBC | Abscess and inflammatory areas |
Iodine 131, 123, 125 (131I, 123I, 125I)![]() | |
Metaiodobenzylguanidine (MIBG) I 131 | Thyroid malignancy total body scanning Pheochromocytoma |
Norcholestenol iodomethyl I 131 | Adrenal gland |
Orthoiodohippurate (OIH) I 131 | Renal function |
Iodide I 123 | Thyroid gland function |
Iofetamine I 123 | Brain scanning |
Fibrinogen I 125 | Deep venous thrombosis |
Thallium 201 (201Tl)![]() | |
Thallium chloride Tl 201 | Cardiac perfusion Parathyroid gland |
Selenium 75 (75Se)![]() | |
Selenomethionine Se 75 | Pancreas |
Gallium 67 (67Ga)![]() | |
Gallium citrate Ga 67 | Body imaging for tumor or inflammatory process |
Xenon 133 (133Xe)![]() | |
Xenon Xe 133 gas | Lung ventilation |
Krypton 81m (81mKr)![]() | |
Krypton Kr 81m gas | Lung ventilation |
Radionuclides and PET and SPECT Diagnostic Scanning![]() | |
Oxygen 15 (15O), nitrogen 13 (13N), carbon 11 (11C), fluorine 18 (18F)![]() | PET scanning |
Gallium 67 (67Ga), thallium 201 (201Tl), technetium 99m (99mTc)![]() | SPECT scanning |
Radionuclides/Radiopharmaceuticals and Laboratory Diagnostic Testing![]() | |
Chromium 51 (51Cr)![]() | |
Chromated Cr 51 sodium | RBC volume and survival time |
Chromated Cr 51 albumin | Gastrointestinal protein loss |
Cobalt 57 (57Co)![]() | |
Cyanocobalamin Co 57 | Pernicious anemia |
Iodine 131, 123, 125 (131I, 123I, 125I)![]() | |
131I or 123I | Thyroid gland function |
125I | Radioassays Total blood volume |
Iodinated I 125 albumin | Plasma volume |
* In this table, radionuclides appear in bold blue type and radiopharmaceuticals appear in regular type. For convention throughout the table and this chapter, radionuclides (i.e., radioactive isotopes) appear as the name of the element and the isotope number, abbreviated after initial mention (e.g., iodine 131 initially, 131I thereafter). Radiopharmaceuticals appear as the name of the drug containing the radionuclide followed by the element symbol, the isotope number, and the carrier agent, if one is used. This table includes the most commonly used pharmaceuticals and does not preclude the use of others for specific studies or laboratory tests.